Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
17.2M
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
5.02M
-
Shares change
-
+1.23M
-
Total reported value, excl. options
-
$29.6M
-
Value change
-
+$7.39M
-
Number of buys
-
22
-
Number of sells
-
-12
-
Price
-
$5.90
Significant Holders of Journey Medical Corp - Common Stock (DERM) as of Q1 2025
43 filings reported holding DERM - Journey Medical Corp - Common Stock as of Q1 2025.
Journey Medical Corp - Common Stock (DERM) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.02M shares
of 17.2M outstanding shares and own 29.18% of the company stock.
Largest 10 shareholders include TANG CAPITAL MANAGEMENT LLC (1.85M shares), WASATCH ADVISORS LP (931K shares), VANGUARD GROUP INC (372K shares), Cambridge Investment Research Advisors, Inc. (338K shares), RENAISSANCE TECHNOLOGIES LLC (238K shares), AMERICAN FINANCIAL GROUP INC (180K shares), PVG ASSET MANAGEMENT CORP (174K shares), GEODE CAPITAL MANAGEMENT, LLC (114K shares), ENVESTNET ASSET MANAGEMENT INC (103K shares), and Opaleye Management Inc. (69.3K shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.